Sign in

BridgeBio Oncology Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Total revenue 0.00 0.00 0.00
Cost of revenue 0.00
Gross profit 0.00
Total operating expenses + 0.15 0.08 0.06 0.00 0.00
Operating income -0.15 -0.08 -0.06 0.00 0.00
Non-operating income (net) 0.01 0.01 0.00 0.00 0.00
Income before tax -0.13 -0.07 -0.06 0.00 0.00
Net income -0.13 -0.07 -0.06 0.00 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Dec-22
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00
Total operating expenses + 0.05 0.04 0.05 0.03 0.02 0.02 0.02 0.02 0.02 0.00 0.00
Operating income -0.05 -0.04 -0.05 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.04 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
Net income -0.04 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Total cash and short-term investments + 0.43 0.13 0.00 0.00 0.00
Accounts receivable, net 0.00
Other current assets 0.00 0.00 0.00
Total current assets 0.43 0.00 0.00
Total non-current assets + 0.02 0.19 0.00 0.00 0.00
Total assets 0.45 0.19 0.00 0.00 0.00
Total current liabilities + 0.04 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.01 0.10
Total liabilities 0.04 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.41 0.19 0.00 0.00 0.00
Common shares outstanding 31 17 20 20 20
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22
Total cash and short-term investments + 0.25 0.43 0.47 0.13 0.14 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.27 0.43 0.48 0.14 0.14 0.00 0.00 0.00 0.00
Total non-current assets + 0.15 0.02 0.01 0.01 0.01 0.19 0.19 0.19 0.19 0.00 0.00 0.00
Total assets 0.42 0.45 0.48 0.15 0.15 0.19 0.19 0.19 0.19 0.00 0.00 0.00
Total current liabilities + 0.04 0.04 0.04 0.03 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.35 0.33 0.01 0.01 0.01 0.01
Total liabilities 0.05 0.04 0.04 0.38 0.35 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.37 0.41 0.45 -0.23 -0.20 0.19 0.19 0.18 0.18 0.00 0.00 0.00
Common shares outstanding 31 31 24 24 24 17 24 24 22 20 20 20 20 20
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Operating cash flow + -0.11 0.00 -0.05
Cash flow from investing + 0.07 -0.18
Cash flow from financing + 0.38 0.19 0.06
Change in cash 0.34 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Dec-22
Operating cash flow + -0.04 -0.04 -0.07 -0.02 0.00 0.00 -0.04 0.00 -0.01
Cash flow from investing + -0.29 0.01 0.07 0.01 0.04 0.00
Cash flow from financing + 0.00 0.00 0.38 0.02 0.00 0.00 0.02 0.20 0.01
Change in cash -0.32 -0.04 0.38 0.01 0.00 0.00 0.02 0.20 0.00 0.00 0.00
5 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Research And Development

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Selling General And Administrative

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Operating Income

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Total Revenue

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Gross Profit

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Common Stock Shares Outstanding

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Common Stock

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Retained Earnings

1Y 2Y 5Y Max
9 days ago